newsfilter
← Latest News
GlobeNewswire·

Invivyd to Present Multiple Posters Highlighting Clinical Data from Adintrevimab During ID Week 2022

WALTHAM, Mass., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Invivyd, (NASDAQ:IVVD), formerly Adagio Therapeutics (NASDAQ:ADGI), a clinical-stage biopharmaceutical company on a mission to protect humanity from serious viral